# Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)

> **NCT00064753** · PHASE2,PHASE3 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 4110 (actual)

## Conditions studied

- Chronic Kidney Disease
- Cardiovascular Disease
- Death

## Interventions

- **DRUG:** High Dose Multivitamin
- **DEVICE:** Low Dose Multivitamin

## Key facts

- **NCT ID:** NCT00064753
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 4110 (ACTUAL)
- **Last updated:** 2017-10-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00064753

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00064753, "Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00064753. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*